Patents


2021

S.No.
REFERENCE
COUNTRY

1.

Isoxylitones Mediated Neurogenesis; Atta-ur-Rahman, M. Iqbal Choudhary, Farzana Shaheen, Shabana Usman Simjee, Saba Majeed, Anila Bashir, and Kanwal Iftikhar; US-Patent No. 11065211 B2, Application No. 15/934539, Patent Date: 20/07/2021.

USA

2.

Bio-catalyzed Synthesis of Potent Anti-Inflammatory Agents from Medroxyprogesterone Acetate; M. Iqbal Choudhary, Saira Bano, Atia-tul-Wahab, Zaheer-ul-Haq, Sammer Yousuf, Almas Jabeen, and Atta-ur-Rahman; US-Patent Publication No. 2021/0380630 A1, Publication Date: 09/12/2021.

USA

3.

Bio-catalyzed Synthesis of New Aromatase Inhibitors through Structural Modifications of Anticancer Drug Formestane; Atia-tul-Wahab, M. Iqbal Choudhary, Rabia Farooq, Nimra Naveed Shaikh, and Atta-ur-Rahman; US-Patent Publication No. 2021/0380630 A1, Publication Date: 09/12/2021.

USA

4.

Synthesis of Anti-Inflammatory and Anti-Cancer Agents through Fungal Transformation of Mibolerone; M. Iqbal Choudhary, Atia-tul-Wahab, Mahwish Siddiqui, Almas Jabeen, Nimra Naveed Shaikh, and Atta-ur-Rahman; US-Patent Publication No. 2021/0369740 A1, Publication Date: 02/12/2021.

USA

5.

Prevention and Treatment of SARS-CoV-2 Infection by Mentha Piperita and Flos Chrysanthemi Extracts Alone, and Their Combination; Atta-ur-Rahman, M. Iqbal Choudhary, Saba Farooq, and Atia-tul-Wahab; US-Patent Publication No. 2021/0361733 A1, Publication Date: 25/11/2021.

USA

6.

Derivatives of 4-Aminoantipyrine as Anti-Alzheimers Butyrylcholinesterase Inhibitors; Hina Siddiqui, M. Iqbal Choudhary, Atia-tul-Wahab, Atta-ur-Rahman, Fazila Rizvi, and Sheeba Wajid; US-Patent Publication No. 2021/0363108 A1, Publication Date: 25/11/2021.

USA

7.

Dietary Herbal Health Supplement for the Management and Treatment of Parkinson’s Disease; M. Iqbal Choudhary, Atia-tul-Wahab, Humaira Zafar, and Atta-ur-Rahman; US-Patent Publication No. 2021/0330726 A1, Publication Date: 28/10/2021.

USA

8.

Nasally Administered Pharmaceutical Composition for the Treatment of Epilepsy and Related Disorders; Farzana Shaheen, Atta-ur-Rahman, M. Iqbal Choudhary, Shabana U. Simjee, and Zehra Batool; US-Patent Publication No. 2021/0322344 A1, Publication Date: 21/10/2021.

USA

9.

Synthesis of New Potent Aromatase Inhibitors Through Biocatalysis of Anti-Cancer Drugs, Atamestane, Drostanolone Enanthate, and Exemestane; Atia-tul-Wahab, M. Iqbal Choudhary, Mahwish Siddiqui, Nimra Naveed Shaikh, Nisha Khan, and Atta-ur-Rahman; US-Patent Publication No. 2021/0308144 A1, Publication Date: 07/10/2021.

USA

10.

Potent Aromatase Inhibitors Through Fungal Transformation of Anti-Cancer Drug Testolactone: An Approach Towards the Treatment of Breast Cancer; M. Iqbal Choudhary, Atia-tul-Wahab, Mahwish Siddiqui, Nimra Naveed Shaikh, Sammer Yousuf, and Atta-ur-Rahman; US-Patent Publication No. 2021/0230214 A1, Publication Date: 29/07/2021.

USA

11.

Nasally Administered Pharmaceutical Composition for the Treatment of Epilepsy and Related Disorders; Farzana Shaheen, Atta-ur-Rahman, M. Iqbal Choudhary, Shabana U. Simjee, and Zehra Batool; European Patent Number: EP3895703, Application Number: EP20210167065, Filing Date: 06-04-2021, Publication Date 20-10-2021.

USA

12.

New Analogues of Medroxyprogesterone Acetate as Potent as Anti-Inflammatory Drugs; M. Iqbal Choudhary, Saira Bano, Atia-tul-Wahab, Sammer Yousuf, Almas Jabeen, and Atta-ur-Rahman; Pakistan Patent Application No. 761/2021, Filing Date: 07/10/2021.

USA

13.

3α, 10β, 17β-Trihydroxy-7α, 17α-dimethyl-5α-estrane for Treating ER+ Breast Cancers; M. Iqbal Choudhary, Atia-tul-Wahab, Mahwish Siddiqui, Nimra Naveed Shaikh, and Atta-ur-Rahman; Pakistan Patent Application No. 661/2021, Filing Date: 07/09/2021.

USA

14.

New Structural Analogues of Exemestane for Treating ER+ Breast Cancers; Atia-tul-Wahab, M. Iqbal Choudhary, Mahwish Siddiqui, Nisha Khan, Nimra Naveed Shaikh, and Atta-ur-Rahman; Pakistan Patent Application No. 660/2021, Filing Date: 07/09/2021.

USA

15.

New Structural Analogues of Drostanolone Enanthate for Treating ER+ Breast Cancers; Atta-ur-Rahman, Atia-tul-Wahab, Mahwish Siddiqui, Nimra Naveed Shaikh, and M. Iqbal Choudhary; Pakistan Patent Application No. 659/2021, Filing Date: 07/09/2021.

USA

16.

1-Dehydro-11α-hydroxy-canrenone for Treating ER+ Breast Cancers; Atia-tul-Wahab, M. Iqbal Choudhary, Ambreen Aziz, Nimra Naveed Shaikh, Sammer Yousuf, and Atta-ur-Rahman; Pakistan Patent Application No. 608/2021, Filing Date: 20/08/2021.

USA

17.

Management and Treatment of Parkinson’s Disease Using Dietary Herbal; M. Iqbal Choudhary, Atta-ur-Rahman, Atia-tul-Wahab, and Humaira Zafar; Pakistan Patent Application No. 458/2021, Filing Date: 21/06/2021.

USA

18.

Bio-catalyzed Synthesis of New Aromatase Inhibitors Trough Structural Modifications of Anticancer Drug Formestane; Atta-ur-Rahman, M. Iqbal Choudhary, Rabia Farooq, Atia-tul-Wahab, and Nimra Naveed Shaikh; Pakistan Patent Application No. 340/2021, Filing Date: 04/05/2021.

USA

19.

Anti-Alzheimer’s Butyrylcholinesterase Inhibitors and Anti-Leishmanial New Derivatives of 4-Aminoantipyrine; Hina Siddiqui, Fazila Rizvi, Sheeba Wajid, Atia-tul-Wahab, Sammer Yousuf, Atta-ur-Rahman, and M. Iqbal Choudhary; Pakistan Patent Application No. 244/2021, Filing Date: 26/03/2021.

USA

20.

Pharmaceutical Composition for the Treatment of Epilepsy and Other Neurological Disorders Through Nasal Application; Farzana Shaheen, Atta-ur-Rahman, M. Iqbal Choudhary, Shabana U. Simjee, and Zehra Batool; China National Intellectual Property Administration, PRC, Publication No: CN113855658A, Publication Date: 31/12/2021, Application No: CN202110381246.8, Filing Date: 08/04/2021.

USA

21.

Indole-Linked 1,2,3, -Triazole Derivatives Alleviate MGO-Mediated Protein Glycation to Prevent Diabetopathies; M. Iqbal Choudhary, Humera Jahan, Nimra Naz Siddiqui, Fatima Z. Basha, Shazia Iqbal, and Atta-ur-Rahman; Pakistan Patent Application No. 137/2021, Filing Date: 16/02/2021.

USA

22.

Prevention and Treatment of SARS-CoV-2 Infection by Mentha Piperita and Flos Chrysanthemi Extracts Alone, and Their Combination, Atta-ur-Rahman, Saba Farooq, Atia-tul-Wahab, and M. Iqbal Choudhary; Pakistan Patent Application No. 125/2021, Filing Date: 10/02/2021.

USA

23.

Indole-based Thiazole Derivatives as Novel Antiglycation Agents for the Treatment and Prevention of Late Diabetic Complications; Humera Jahan, M. Iqbal Choudhary, Umair Aleem, Asad Ullah, Bina S. Siddiqui, Sabira Begum, and Atta-ur-Rahman; Pakistan Patent Application No. 43/2021, Filing Date: 05/01/2021.

USA

 

2020

24.

A New Dietary Health Supplement for the Management and/or Treatment of Age Related Neurodegenerative Diseases Including Parkinson’s Disease, M. Iqbal Choudhary, Atta-ur-Rahman, Atia-tul-Wahab, Humaira Zafar, US Patent No. US 10,849,953 B1, Patent Date: 01/12/2020.

USA

25.

New Potent Aromatase Inhibitors Through Fungal for Transformation of Anti-Cancer Drug Testolactone: An Approach Towards the Treatment of Breast Cancer; M. Iqbal Choudhary, Atia-Tul-Wahab, Mahwish Siddiqui, Nimra Naveed Shaikh, Sammer Yousuf, and Atta-ur-Rahman; Pakistan Patent Application No. 621/2020, Filing Date: 24/9/2020.

USA

26.

Synthesis of a New Potent Aromatase Inhibitor through Biocatalysis of Anticancer Drug Atamestane, M. Iqbal Choudhary, Atia-tul-Wahab, Mahwish Siddiqui, Nimra Naveed Shaikh, and Atta-ur-Rahman; Pakistan Patent Application No. 475/2020, Filing Date: 22/7/2020.

USA

27.

New Aromatase Inhibitors Through Aspergillus Niger-Mediated Transformation of Anabolic Drug Mibolerone, M. Iqbal Choudhary, Atia-tul-Wahab, Mahwish Siddiqui, Nimra Naveed Shaikh, and Atta-ur-Rahman, Pakistan Patent Application No. 687/2020, Filing Date: 08/10/2020.

USA

28.

Nasally Administered Formulation for the Treatment of Epilepsy and Related Disorders; Farzana Shaheen, Atta-Ur-Rahman, M. Iqbal Choudhary, Shabana U. Simjee, and Zehra Batool; Pakistan Patent Application No. 505/2020, Filing Date: 30/7/2020.

USA

 

2019

29.

A New Dietary Health Supplement for the Management and/or Treatment of Age Related Neurodegenerative Diseases Including Parkinson’s Disease, M. Iqbal Choudhary, Atta-ur-Rahman, Atia-tul-Wahab, and Humaira Zafar, Submission Granted Date 31-5-2019, -Patent Application No. 2019-0528.

USA

30.

A New Dietary Health Supplement for the Management and /or Treatment of Age Related Neurodegenerative Diseases Including Parkinson’s Disease, M. Iqbal Choudhary, Atta-ur-Rahman, Atia-tul-Wahab, and Humaira Zafar, Application Date 26-8-2019, Patent Application No. 578/2019.

 

2018

31.

Isoxylitones mediated neurogenesis, Atta-ur-Rahman, M. Iqbal Choudhary, Farzana Shaheen, Shabana Usman Simjee, Saba Majeed, Anila Bashir, and Kanwal Iftikhar, US-Patent Publication Ref. No. 2018.0308.

USA

32.

4-dinitroanilino-benzoic Acid: Novel Insulinotropic Agent for the Treatment of Diabetes, Humera Jahan,M. Iqbal Choudhary,Mehwish Manzoor, Khalid M. Khan and Atta-ur-Rahman, United States Patent 10183000, U. S. Patent Application Serial No. 15/682,6232,Ref. 2018.0620.

USA

 

2017

33.

4-Hydroxybenzohydarzide-A New Class of Angiogenic Enzyme Thymidine Phosphorylase Inhibitors, M. Iqbal Choudhary, Sumaira Javaid, M. Khan, Khalid, Syed M. Saad, Atia-tul Wahab, Atta-ur- Rahman, US-Patent Publication No. 20170246130, Application No. 15/053887, Filing Date: 02/25/2016, Publication Date: 08/31/2017.

USA

34.

Potent Inhibitors of Human Carbonic Anhydrase II and Bovine Carbonic Anhydrase II and their Mechanism of Action, M. I. Choudhary, M. Saleem, A. S. Bhatti, Atia-tul-Wahab, A. Khan, Atta-ur-Rahman, US-Patent Publication No. 20170073306, Application No. 14/854,981, Filing Date: 9/15/2015, Publication Date: 03/16/2017.

USA

35.

2,4-Dinitroanilinobenzoic acid, novel insulinotropic agent for the treatment of diabetes Jahan H, Choudhary MI, Manzoor M, Khan KM, and Atta-ur-RahmanFiling date: Aug 22, 2017 US Patent 2017.0620

USA

 

2016

36.

Anthranilic Acid Derivatives: Novel Inhibitors of Advanced Glycation End- Products (AGEs) Formation M. Iqbal Choudhary, Humera Jahan, Khalid M. Khan, Amber Ata, Atta-ur-Rahman, US Patent US9,381,182 B2 July 5, 2016

USA

37.

Inhibitors of Advanced Glycation End-Products (AGEs) Formation Humera Jahan, M. Iqbal Choudhary, Zarbad Shah, Khalid M. Khan, Atta-ur-RahmanJuly 12, 2016 US Patent US9,387,198 B1

USA

 

2015

38.

Schiff Bases of Thiazoles: A New Class of Urease Inhibitors, Muhammad Iqbal Choudhary, K. M. Khan, A. Khan, N. Ambreen, Atia-tul-Wahab, Atta-ur-Rahman , US-Patent Publication No. 2015/0368214, US-Patent Application No. 14/310,738, Filing Date: 06/20/2014, Publication Date: 12/24/2015.

USA

39.

Thiourea Derivatives as a-Chymotrypsin Inhibitors, Atta-ur-Rahman, M. I.Choudhary, Bishnu P. Marasini, K. M. Khan, F. Sheikh, Atia-tul-Wahab, US-Patent Publication No. 2015/0080580, Application No. 14/030,817, Filing Date: 09/18/2013, Publication Date: 3/19/ 2015.

USA

40.

Synthesis and Biological Studies of an Isomeric Mixture of (E/Z) Isoxylitones and Its Analogues, Atta-ur-Rahman, M. I. Choudhary, F. Shaheen, S. U. Simjee, Noureen Khan, S.M. Malhi, S. U. Ali Shah, M. N. Ashraf, US-Patent Publication No. 2015/0148417, Application No. 14/609/211, Filing Date: 1/29/2015, Publication Date: 05/28/2015.

USA

41.

Anti-Glycation Properties of Oxindole Derivatives, M. I. Choudhary, S. Rasheed, N.Ahmed, K. M. Khan, M. Khan, Atta-ur-Rahman, Atia-tul-Wahab, US-Patent Publication No. 2015/0038543, Application No. 13/954,648, Filing Date: 07/30/2013, Publication Date: 2/5/ 2015.

USA

42.

Anthranilic Acid Derivatives: Novel Inhibitors of Advanced Glycation end Products (Ages) Formation, M. I.Choudhary, H. Jahan, K.M. Khan, Amber Atta-tul-Wahab, Atta-ur-Rahman, US-Patent Publication No. 2015/0051286, Application No. 13/968,071, Filing Date: 08/15/2013, Publication Date: 2/19/2015.

USA

43.

Thiourea Derivatives, M. I. Choudhary, S. Farooq, K. M. Khan, F. Naz, Atia-tul-Wahab, Atta-ur Rahman, US-Patent Publication No. 2015/0335594, Application No. 14/285213, Filing Date: 05/22/2014, Publication Date: 11/26/2015.

USA

 

2014

44.

Artonin I to Treat Resistant Infectious Staphylococcus Aureus, M. Iqbal Choudhary, S. Farooq, Atia-tul-Wahab, Christian D. A. Fozing, Atta-ur-Rahman, US-Patent No.:8,889,733, Application No. 13/740,919, Patent date: 11/18/ 2014.

USA

45.

Overcoming Antibiotic Resistance in Staphylococcus Aureus by New Thiruea Dervatives, M. Iqbal Choudhary, S. Farooq, K.M. Khan, F. Naz, Atia-tul-Wahab and Atta-ur-Rahman, 2014.

USA

46.

3-amino-α2-α (4-α nitrophenyl)α -α 4-α (3H)α -α quinazolinone or derivatives thereof for treating or preventing hepatitis C virus infection ,ShiekhRiazuddin,Osman. Ali, Usman Ashfaq, Shaheen N. Khan, JavedAkram, Atta-ur-Rahman, M. Iqbal Choudhary, Khalid M. Khan, Zulfiqar Ali Khan. U.S. Patent No. 8,809,354 B2 Application Serial No. 20130171101 A1 20130704, Publication date Aug 19, 2014

USA

 

2013

47.

Quinazolines as -gliucuronidase Novel Inhibitors, M. Iqbal Choudhary, Khalid M. Khan, Nimra naveed Shaikh, M. Saad, Sammer Yousuf and Atta-ur-Rahman, U.S. Patent Application Serial No. 13/789,021; Our Ref. 2013.0202

USA

 

2012

48.

Method of Producing Tibolone Metabolites by Fermentation with Rhizopus stolonifer, Atta-ur-Rahman, M. Iqbal Choudhary, S. A. A. Shah, S. N. Khan,
Patent No. US 8,148,556 B2. Dated 03/04/2012, USA.

USA

 

2012

49.

Method of Producing Tibolone Metabolites by Fermentation with Gibberella fujikuroi, Atta-ur-Rahman, M. Iqbal Choudhary, S. A. A. Shah, S. N. Khan, Patent No. US 8,148,557 B2. Dated 03/04/2012, USA.

USA

50.

Method of Producing Tibolone Metabolites by Fermentation with Fusarium lini, Atta-ur-Rahman, M. Iqbal Choudhary, S. A. A. Shah, S. N. Khan, Patent No. US 8,148,558 B2. Dated 03/04/2012, USA.

USA

51.

Novel Hydroxylated Enantiomers of (-) 3a,6,6,9a-tetramethylperhydronaphtho[2,1-b]furan as Perfuming Agents Derived from a Fungal Fermentation Process, Atta-ur-Rahman, Muhammad Iqbal Choudhary, Syed Ghulam Musharraf, Amtul Sami, United States Patent Application 20120301956Application Number: 13/115991, Publication Date, 11/29/2012.

USA

52.

7-Nitro-2-(3-nitro phenyl)-4H-3,1-benzoxazin-4-one or Derivatives Thereof for Treating or Preventing Antiviral Infections, Atta-Ur-Rahman, US8148368 (Patent), 2012

USA

53.

Formulations Against Cutaneous Leishmaniasis, Atta-ur-Rahman, Muhammad Iqbal Choudhary, Sammer Yousuf, Samreen Khan, Farooq Rahman Soomro, Shahida Perveen, United States Patent 8287921, Application Number, 13/189509, Publication Date, 10/16/2012.

USA

54.

Method of Producing Tibolone Metabolites by Fermentation with Cunninghamella elegans, Atta-ur-Rahman, Muhammad Iqbal Choudhary, Syed Adnan Ali Shah, Shamsun Nahar Khan, United States Patent 8198041, Application Number, 13/015553, Publication Date, 06/12/2012

USA

55.

7-Nitro-2-(3-nitro phenyl)-4H-3,1-benzoxazin-4-one or Derivatives Thereof for Treating or Preventing Antiviral Infections, Shaikh Riazuddin, Atta-ur Rahman, Usman Zafar, Muhammad Iqbal Choudhary, Usman Ali Ashfaq, Khalid M Khan, Tayyab Husnain, Zulfiqar Ali Khan, Javed Akram, United States Patent 8148368, Application Number, 2/876999 Publication Date,04/03/2012.

USA

56.

Quinazolines as β-Glucuronidase Novel Inhibitors,Muhammad Iqbal Choudhary, Khalid Mohammed Khan, Nimra Naveed Shaikh, Syed Muhammad Saad, Sammer Yousuf and Atta-ur-Rahman (2012)

USA

 

2011

57.

Method of Producing Tibolone Metabolites by Fermentation with Cunninghamella elegans, Atta-Ur-Rahman, US US8198041 B2 (Patent), (2011)

USA

 

2009

58.

Tyrosinase Enzyme Inhibitors from Fungal Hydroxylation of Tibolone, M. Iqbal Choudhary, Atta-ur-Rahman, S. A. A. Shah, M. T. H. Khan, Patent No. US 2009/0136434 A1. Dated 05-28-2009. USA

USA

59.

Alpha-Glucosidase Inhibitors from Fungal Hydroxylation of Tibolone and Hydroxytibolones, M. Iqbal Choudhary, Atta-ur-Rahman, S. A. Ali Shah, S. N. Khan, Patent No. US 2009/0137542 A1. Dated 05-28-2009. USA.

USA

 

2008

60.

New Anticonvulsant Compounds, United States Patent 20080004353, Atta-ur-Rahman, M. Iqbal Choudhary, F. Shaheen, A. Ganesan, S. U. Simjee, M. Raza, Application Number:11/307251, Publication Date:, 01/03/2008, USA.

USA

61.

New -glucosidase inhibitors and antibacterial compounds from Myrtus communis L. Atta-ur-Rahman, M. Iqbal Choudhary, F. Shaheen, M. Ahmad, S. Nahar Khan, S. Anjum, US Patent (Application # 11306345). USA.

USA

 

2005

62.

Novel Hydroxylated Enantiomers of (-)-3µ,6,6,9µ-tetramethylperhydronaptho[2,1-b]furan as perfuming agents derived from fungal fermentation process, M. Iqbal Choudahry, Atta-ur-Rahman and S. Ghulam Musarraf, US Patent Application No. 10/907,48, dated 04-02-2005, USA.

USA

 

2002

63.

Sum fraction polyphenols of Tamarix ramosissima ( Tamaricaceae) possess antifungal activity, N. A. Sultanova, T. Makhmoor, V. B. Omurkamzinova, M. Iqbal Choudahry, Atta-ur-Rahman, Zh. A. Abilov, Patent No 11936, А 61К 35/78, Bulletin No 9 dated 16-09-2002.

Kazakhstan

 

1997

64.

A Process for High Yield Extraction of Essential Oils of Spices, Atta-ur-Rahman, M. Iqbal and Aftab Ahmed, Pakistan Patent No. 135689, dated 16-02-1997.

Pakistan

65.

A Preparation of Novel Composite Essential Oil Mixture which is Identical to Famous Garam Masala (Mixture of Spices), Atta-ur-Rahman, M. Iqbal, Aftab Abmed and Afgan Farooq, Pakistan Patent No. 135652, dated 23-01-1997.

Pakistan

 

1992

66.

Plant Based Anti-diarrhoeal Drug and Abdominal Pain Reliever, Atta-ur-Rahman and M.I. Choudhary, Pakistan Patent Application No. 236/92, dated 18-5-92.

Pakistan

67.

Demulsification of B.F.O/water in Oil Turbine Power Stations, Atta-ur-Rahman, M.I. Choudhary and K.M. Khan, Pakistan Patent Application No. 213/92, dated 10-5-92.

Pakistan

 

1984

68.

A Rapid Procedure for the Isolation of Vinblastine from the Leaves of Catharanthus roseus, Atta-ur-Rahman, J. Fatima and A.N. Mistry, Pakistan Patent No. 128340, dated 14-2-1984.

Pakistan

69.

A New Procedure for the Isolation of Vinblastine from the Leaves of Catharanthus roseus, Atta-ur-Rahman and M. Bashir, Pakistan Patent No. 128636, dated 21-10-1984.

Pakistan

 

1983

70.

A New Procedure for the Isolation of Vinblastine from the Leaves of Catharanthus roseus, Atta-ur-Rahmanand M. Bashir, Pakistan Patent No. 128638, dated 18-4-1983.

Pakistan

 

1980

71.

A Rapid Procedure for the Isolation of Catharanthine and Vindoline from Leaves of Catharanthus roseus, Atta-ur-Rahman, M. Bashir, M. Hafeez, and N. Perveen, Pakistan Patent, Appl. No. 175/80, dated 4-6-1980.

Pakistan

 

1978

72.

Methods for the Syntheses of Vinblastine, 20-Epivinblastine (Vinrosidine), 15-Hydroxy-20-Deoxyvinblastine, Vincristine and other Novel Intermediates, Atta-ur-Rahman, Pakistan Patent No. 126852, dated 14-2-1978.

Pakistan

 

1977

73.

Synthesis of Vinblastine, Vincristine and Vinrosidine, Atta-ur-Rahman, Germany Patent No. 2614863, dated 13-10-1977.

Germany

 

1976

74.

The Synthesis of Vinblastine, Vincristine and Vinrosidine, Atta-ur-Rahman, British Patent No. 1551054, dated 7-5-1976.

UK